Your account is not claimed yet. You can sign up with ORCID to claim your account.

Gilda P Chau (Gilda Chau)

Years Active: 2020-2023
Publications (10 Years): 5

University of Texas MD Anderson Cancer Center

Texas A&M University Kingsville (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas MD Anderson Cancer Center Oct 30o 2000

United States

Senior Research Assistant :: Genetics

Education History

Texas A&M University Kingsville

United States

MSC :: Animal Science and Veterinary Technology

Publications

Denada Dibra, Mihai Gagea, Yuan Qi, Gilda P Chau, Xiaoping Su, Guillermina Lozano
p53R245W mutation fuels cancer initiation and metastases in NASH-driven liver tumorigenesis. Cancer research communications (2023)
Shunbin Xiong, Dhruv Chachad, Yun Zhang, Jovanka Gencel-Augusto, Mario Sirito, Vinod Pant, Peirong Yang, Chang Sun, Gilda P Chau, Yuan Qi, Xiaoping Su, Elizabeth M Whitley, Adel K El-Naggar, Guillermina Lozano
Differential Gain-of-Function Activity of Three p53 Hotspot Mutants In Vivo. Cancer research 82 (10) (2022)
Vinod Pant, Neeraj K Aryal, Shunbin Xiong, Gilda P Chau, Natalie Wall Fowlkes, Guillermina Lozano
Alterations of the Mdm2 C-Terminus Differentially Impact Its Function In Vivo. Cancer research 82 (7) (2022)
Chang Sun, Jeannelyn S Estrella, Elizabeth M Whitley, Gilda P Chau, Guillermina Lozano, Amanda R Wasylishen
Context matters - Daxx and Atrx are not robust tumor suppressors in the murine endocrine pancreas. Disease models & mechanisms 15 (8) (2022)
Amanda R Wasylishen, Chang Sun, Sydney M Moyer, Yuan Qi, Gilda P Chau, Neeraj K Aryal, Florencia McAllister, Michael P Kim, Michelle Craig Barton, Jeannelyn S Estrella, Xiaoping Su, Guillermina Lozano
Daxx maintains endogenous retroviral silencing and restricts cellular plasticity in vivo. Science advances 6 (32) (2020)

Gilda P Chau.css-eqlu8i{font-size:small;padding-left:4px;} (Gilda Chau)